A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer is Associated with a High Incidence of Brain Metastasis
Cancer research and treatment : official journal of Korean Cancer Association
The impact of epidermal growth factor receptor (EGFR) mutation in locally advanced non-small-cell lung cancer (NSCLC) remains controversial. This study was conducted to investigate the clinical outcomes and recurrence patterns after definitive chemoradiotherapy (CRT) in patients with unresectable stage III non-squamous-cell lung cancer according to EGFR mutation status. We retrospectively reviewed 604 patients with pathologically confirmed stage III NSCLC who were treated with definitive CRTdoi:10.4143/crt.2022.388 pmid:36228655 fatcat:aaivy2lbinghhc2aeyg6p6np2i